Zukowski M, Bohatyrewicz R, Krawczyk A A
Clinic of Anaesthesiology and Intensive Care, Pomeranian Medical University Szczecin, Szczecin, Poland.
Transplant Proc. 2007 Nov;39(9):2724-6. doi: 10.1016/j.transproceed.2007.09.012.
The serum creatinine level is one of the earliest metrics of kidney metabolic function. We examined 146 potential donors and their 232 kidney recipients. Donor data included gender, age, cause of death, mean arterial pressure (MAP), central venous pressure (CVP), pulmonary capillary wedge pressure (PCWP), systemic vascular resistance index, cardiac output (CO), and dopamine consumption. Recipient data were age, gender, time of hemodialysis before transplantation, panel reactive antibodies (PRA), cold ischemia time (CIT), etiology of renal insufficiency, duration/number of postoperative dialyses and serum creatinine levels on posttransplant days 1, 2, 3, 7, 14, 30, 90 and 180 day. Univariate correlates of higher serum creatinine levels in kidney recipients were CIT, time of hemodialysis before transplantation, PRA level as well as donor MAP, CVP, and PCWP. Multivariate analysis revealed that MAP < 70 mmHg in organ donors and CIT > 24 hours contributed to higher serum creatinine levels in kidney recipients up to 14 days posttransplantation (P < .01). There was a significant relation (P < .02) between low donor CO or CVP and an increased recipient serum creatinine level after 14 days posttransplantation. We concluded that decreased donor MAP and prolonged CIT predicted higher creatinine level in kidney recipients in the first 14 days posttransplantation. Donor CO and CVP influenced later serum creatinine levels in kidney recipients.
血清肌酐水平是肾脏代谢功能最早的指标之一。我们研究了146名潜在供体及其232名肾脏受者。供体数据包括性别、年龄、死因、平均动脉压(MAP)、中心静脉压(CVP)、肺毛细血管楔压(PCWP)、全身血管阻力指数、心输出量(CO)和多巴胺消耗量。受者数据包括年龄、性别、移植前血液透析时间、群体反应性抗体(PRA)、冷缺血时间(CIT)、肾功能不全的病因、术后透析的持续时间/次数以及移植后第1、2、3、7、14、30、90和180天的血清肌酐水平。肾脏受者血清肌酐水平较高的单因素相关因素为CIT、移植前血液透析时间、PRA水平以及供体的MAP、CVP和PCWP。多因素分析显示,器官供体的MAP<70 mmHg和CIT>24小时会导致肾脏受者移植后14天内血清肌酐水平升高(P<.01)。供体CO或CVP较低与移植后14天受体血清肌酐水平升高之间存在显著关系(P<.02)。我们得出结论,供体MAP降低和CIT延长预示着肾脏受者移植后前14天肌酐水平升高。供体CO和CVP影响肾脏受者后期的血清肌酐水平。